Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eli Lilly DRC | CBOE Canada | Salute | Prodotti farmaceutici | 1 Bln CA$ | 84,8x | 1,19 | 29,50 CA$ | 5,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
UnitedHealth DRC | CBOE Canada | Salute | Fornitori e servizi sanitari | 786,15 Mrd CA$ | 39x | -1,14 | 29 CA$ | 0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Johnson Johnson DRC | CBOE Canada | Salute | Prodotti farmaceutici | 522,65 Mrd CA$ | 25,3x | -0,47 | 20,57 CA$ | -0,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Abbvie DRC | CBOE Canada | Salute | Prodotti farmaceutici | 451 Mrd CA$ | 62,9x | -2,87 | 26,26 CA$ | 2,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Thermo Fisher Scientific DRC | CBOE Canada | Salute | Attrezzature e forniture medicali | 275,80 Mrd CA$ | 32x | 7,02 | 19,16 CA$ | -0,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Pfizer DRC | CBOE Canada | Salute | Prodotti farmaceutici | 205,34 Mrd CA$ | 34,3x | -0,57 | 11,99 CA$ | -1,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
CVS Health DRC | CBOE Canada | Salute | Fornitori e servizi sanitari | 104,58 Mrd CA$ | 14,9x | -0,36 | 14,67 CA$ | -2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Bausch Lomb | Toronto | Salute | Attrezzature e forniture medicali | 9,75 Mrd CA$ | -18,9x | 0,24 | 27,77 CA$ | 1,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 1,1% Rialzo | Fai l’upgrade a Pro+ | |
Bausch Health | Toronto | Salute | Prodotti farmaceutici | 4,08 Mrd CA$ | -16,1x | -0,2 | 11,10 CA$ | -0,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -28,1% Ribasso | Fai l’upgrade a Pro+ | |
Curaleaf | Toronto | Salute | Prodotti farmaceutici | 2,08 Mrd CA$ | -7x | -0,12 | 2,77 CA$ | 0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
dentalcorp Holdings | Toronto | Salute | Fornitori e servizi sanitari | 1,75 Mrd CA$ | -22,4x | 0,26 | 9,11 CA$ | -0,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 32,7% Rialzo | Fai l’upgrade a Pro+ | |
Tilray | Toronto | Salute | Prodotti farmaceutici | 1,73 Mrd CA$ | -5x | -0,06 | 1,91 CA$ | -3,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 34,7% Rialzo | Fai l’upgrade a Pro+ | |
Andlauer | Toronto | Salute | Fornitori e servizi sanitari | 1,66 Mrd CA$ | 27x | 43,44 CA$ | 3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 11% Rialzo | Fai l’upgrade a Pro+ | ||
Trulieve Cannabis | CSE | Salute | Prodotti farmaceutici | 1,60 Mrd CA$ | -8,9x | -0,12 | 8,45 CA$ | 1,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Sienna Senior Living | Toronto | Salute | Fornitori e servizi sanitari | 1,39 Mrd CA$ | 40,1x | 0 | 16,81 CA$ | 0,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 13,6% Rialzo | Fai l’upgrade a Pro+ | |
WELL Health | Toronto | Salute | Fornitori e servizi sanitari | 1,32 Mrd CA$ | 17,6x | 0,02 | 5,30 CA$ | 1,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Cronos | Toronto | Salute | Prodotti farmaceutici | 1,12 Mrd CA$ | -17x | -0,29 | 2,93 CA$ | -1,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -5,5% Ribasso | Fai l’upgrade a Pro+ | |
Extendicare Inc | Toronto | Salute | Fornitori e servizi sanitari | 862,21 Mln CA$ | 13,5x | 0,08 | 10,33 CA$ | 0,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 1,2% Rialzo | Fai l’upgrade a Pro+ | |
DRI Healthcare Trust | Toronto | Salute | Prodotti farmaceutici | 691,54 Mln CA$ | 43,8x | -0,5 | 12,22 CA$ | -0,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Canopy Growth | Toronto | Salute | Prodotti farmaceutici | 584,75 Mln CA$ | -0,8x | -0,01 | 5,55 CA$ | -4,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 18,2% Rialzo | Fai l’upgrade a Pro+ | |
Cresco Labs | CSE | Salute | Prodotti farmaceutici | 581,06 Mln CA$ | -6,1x | -0,07 | 1,67 CA$ | 10,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Vitalhub | Toronto | Salute | Attrezzature e forniture medicali | 566,81 Mln CA$ | 160,4x | -8,05 | 10,80 CA$ | 0,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 19,9% Rialzo | Fai l’upgrade a Pro+ | |
Knight Therapeutics Inc | Toronto | Salute | Prodotti farmaceutici | 533,25 Mln CA$ | -17,4x | 0,05 | 5,29 CA$ | 0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 30,4% Rialzo | Fai l’upgrade a Pro+ | |
Medical Facilities Corp | Toronto | Salute | Fornitori e servizi sanitari | 375,67 Mln CA$ | 14,2x | 0,05 | 15,99 CA$ | -1,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -0,2% Ribasso | Fai l’upgrade a Pro+ | |
Cipher Pharmaceuticals Inc | Toronto | Salute | Prodotti farmaceutici | 366,42 Mln CA$ | 15,6x | -0,34 | 14,40 CA$ | 1,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 18,1% Rialzo | Fai l’upgrade a Pro+ | |
Bright Minds Biosciences | CSE | Salute | Ricerca medica e biotecnologica | 366,39 Mln CA$ | -60,4x | -1,45 | 52,73 CA$ | 6,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Hamilton Thorne | Toronto | Salute | Attrezzature e forniture medicali | 343,80 Mln CA$ | -113,3x | 2,63 | 2,23 CA$ | -0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 2,3% Rialzo | Fai l’upgrade a Pro+ | |
Aurora Cannabis | Toronto | Salute | Prodotti farmaceutici | 342,22 Mln CA$ | -7,4x | -0,13 | 6,24 CA$ | -2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 38% Rialzo | Fai l’upgrade a Pro+ | |
Cybin | CBOE Canada | Salute | Ricerca medica e biotecnologica | 299,64 Mln CA$ | -1,7x | -0,15 | 15 CA$ | 1,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Profound Medical | Toronto | Salute | Attrezzature e forniture medicali | 267,58 Mln CA$ | -5,9x | -1,39 | 10,85 CA$ | 2,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |